Ngā hua rapu - David Drobne

  • E whakaatu ana i te 1 - 7 hua o te 7
Whakamahine hua
  1. 1
    Oxidative stress-related biomarkers as promising indicators of inflammatory bowel disease activity: A systematic review and meta-analysis

    Oxidative stress-related biomarkers as promising indicators of inflammatory bowel disease activity: A systematic review and meta-analysis mā Armando Tratenšek, Igor Locatelli, Iztok Grabnar, David Drobne, Tomaž Vovk

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Down‐regulation of micro<scp>RNA</scp>s of the <i>miR‐200</i> family and up‐regulation of Snail and Slug in inflammatory bowel diseases — hallmark of epithelial−mesenchymal transition

    Down‐regulation of micro<scp>RNA</scp>s of the <i>miR‐200</i> family and up‐regulation of Snail and Slug in inflammatory bowel diseases — hallmark of epithelial−mesenchymal transit... mā Nina Zidar, Emanuela Boštjančič, Miha Jerala, Nika Kojc, David Drobne, Borut Štabuc, Damjan Glavač

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy

    Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy mā Filip Baert, David Drobne, Ann Gils, Niels Vande Casteele, Scott Hauenstein, Sharat Singh, S. Lockton, Paul Rutgeerts, Séverine Vermeire

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective

    Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective mā Laimas Virginijus Jonaitis, Srdjan Marković, Klaudia Farkas, Liana Gheorghe, Željko Krznarić, Riina Salupere, Viktorija Mokricka, Zoya Spassova, Dimo Gatev, Isabella Grosu, Anton Lijović, Olga Mitrović, Mateja Saje, Eszter Schäfer, Viktor Uršič, Tina Roblek, David Drobne

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives

    Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives mā Konstantinos Papamichael, Waqqas Afif, David Drobne, Marla C. Dubinsky, Marc Ferrante, Peter M. Irving, Nikolaos Kamperidis, Taku Kobayashi, Paulo Gustavo Kotze, Jo Lambert, Nurulamin M Noor, Xavier Roblin, Giulia Roda, Niels Vande Casteele, Andrés Yarur, Naila Arebi, Silvio Danese, Stéphane Paul, William J. Sandborn, Séverine Vermeire, Adam S. Cheifetz, Laurent Peyrin‐Biroulet

    I whakaputaina 2022
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy

    Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy mā Uri Kopylov, Jurij Hanžel, Claire Liefferinckx, Davide De Marco, Nicola Imperatore, Nikolas Plevris, Iria Bastón‐Rey, Richard Harris, Marie Truyens, Viktor Domislović, Stephan R. Vavricka, Vince Biemans, Sally Myers, Shaji Sebastian, Shomron Ben–Horin, Yago González Lama, Cyrielle Gilletta, Bar‐Gil Shitrit Ariella, Zuzana Zelinková, Roni Weisshof, Darragh Storan, Eran Zittan, Klaudia Farkas, Tamás Molnár, Denis Franchimont, Anneline Cremer, Waqqas Afif, Fabiana Castiglione, Charlie W. Lees, Manuel Barreiro‐de Acosta, Triana Lobatón, Glen Doherty, Željko Krznarić, Marieke Pierik, Frank Hoentjen, David Drobne

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Endoscopic Postoperative Recurrence in Crohn’s Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study

    Endoscopic Postoperative Recurrence in Crohn’s Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre E... mā Henit Yanai, A Kagramanova, O. V. Knyazev, João Sabino, Shana Haenen, Gerassimos J. Mantzaris, Katerina Mountaki, Alessandro Armuzzi, Daniela Pugliese, Federica Furfaro, Gionata Fiorino, David Drobne, Tina Kurent, Sharif Yassin, Nitsan Maharshak, Fabiana Castiglione, Roberto de Sire, Olga Maria Nardone, Klaudia Farkas, Tamás Molnár, Željko Krznarić, Marko Brinar, E. Yu. Chashkova, Moran Livne Margolin, Uri Kopylov, Cristina Bezzio, Ariella Bar‐Gil Shitrit, Milan Lukáš, María Chaparro, Marie Truyens, Stéphane Nancey, Triana Lobatón, Javier P. Gisbert, Simone Saibeni, P Bacsúr, Peter Bossuyt, Julien D. Schulberg, Frank Hoentjen, Chiara Viganò, Andrea Palermo, Joana Torres, Joana Revés, Konstantinos Κarmiris, Magdalini Velegraki, Edoardo Savarino, Panagiotis Markopoulos, Eftychia Tsironi, Pierre Ellul, Cristina Suárez, Roni Weisshof, Dana Ben-Hur, Timna Naftali, Carl Eriksson, Ioannis E. Κoutroubakis, Kalliopi Foteinogiannopoulou, Jimmy K. Limdi, Eleanor Liu, Gerard Surís, Emma Calabrese, Francesca Zorzi, Rafał Filip, Davide Giuseppe Ribaldone, Yifat Snir, Idan Goren, Hagar Banai-Eran, Yelena Broytman, Hadar Amir Barak, Irit Avni‐Biron, Jacob E. Ollech, Iris Dotan, Maya Aharoni Golan

    I whakaputaina 2022
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: